The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients

This study has been registered at ClinicalTrials.gov (NCT05043246).

http://link.springer.com/10.1007/s10096-023-04566-0

Source: European Journal of Clinical Microbiology and Infectious Diseases - February 28, 2023 Category: Microbiology Source Type: research

More News: Coronavirus | Covid Vaccine | COVID-19 | Infectious Diseases | Microbiology | Respiratory Medicine | SARS | Study | Tuberculosis | Vaccines